Search

everythinglearnresearchcommunity

for

Search:↓

Fear of hair-related issues causes significant mental distress, especially in high-stress women.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

COVID-19 may harm male fertility and damage the reproductive system.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Iron deficiency is not a significant cause of hair loss in women.

Chinese medicine may help hair growth and reduce hair loss in androgenetic alopecia.

Bath PUVA therapy works well for a skin condition without as many cancer risks and is cheaper, and iron deficiency might not cause female hair loss.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

Monocytes might be linked to hair loss after COVID-19.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

Traditional Chinese Medicine may help treat hair loss but needs more research.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Syphilis patients showed abnormal hair root changes, with no difference between primary and secondary stages.

New understanding and treatments for hair loss are improving, but more research is needed.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

The document concludes that proper recognition and treatment of skin appendage disorders are important for management.

Minoxidil effectively treats female pattern hair loss.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Screening for the NUDT15 gene variant can prevent severe side effects from thiopurine drugs in East-Asian people.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Certain diseases like AIDS and lupus can make African hair become silky.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.